Improvement from baseline in Psoriasis Area and Severity Index score of 75 % , 90 % , and 100 % at week 12 ; static Physician Global Assessment ( 0/1 ) score ; Dermatology Life Quality Index response ; and Psoriasis Symptom Inventory response were evaluated within subgroups .